Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai-Cheng Hsu

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Plos One|October 14, 2016
Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine DeficiencyKai-Cheng Hsu, Feng-Sheng Wang
Bioinformatics (Oxford, England)|October 1, 2013
Fuzzy optimization for detecting enzyme targets of human uric acid metabolismKai-Cheng Hsu, Feng-Sheng Wang
Plos One|June 15, 2017
Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivityKai-Cheng Hsu, Feng-Sheng Wang
Computers in Biology and Medicine|September 14, 2010
Detection of seizures in EEG using subband nonlinear parameters and genetic algorithmKai-Cheng Hsu, Sung-Nien Yu
Marine Drugs|December 2, 2017
Structural Insights into the Cytotoxic Mechanism of Vibrio parahaemolyticus PirA<sup>vp</sup> and PirB<sup>vp</sup> ToxinsShin-Jen Lin, Kai-Cheng Hsu, Hao-Ching Wang
International Journal of Data Mining and Bioinformatics|April 7, 2012
GemAffinity: a scoring function for predicting binding affinity and virtual screeningKai-Cheng Hsu, Yen-Fu Chen, Jinn-Moon Yang
Journal of Environmental Management|March 22, 2026
Environmental impact level prediction for inorganic and organic chemicals using machine learning models and interpretability analysisChao-Hsu Yang, Kai-Cheng Hsu, Pei-Te Chiueh
BMC Bioinformatics|February 24, 2011
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysisKai-Cheng Hsu, Yen-Fu Chen, Shen-Rong Lin, et al.
American Journal of Cancer Research|November 14, 2019
p38α/S1P/SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinomaPei-Ming Yang, Yi-Han Hong, Kai-Cheng Hsu, et al.
Molecules (Basel, Switzerland)|December 3, 2020
Anti-Inflammatory and Tau Phosphorylation-Inhibitory Effects of EupatinChing-Hsuan Chou, Kai-Cheng Hsu, Tony Eight Lin, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Plos One|October 14, 2016
Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine DeficiencyKai-Cheng Hsu, Feng-Sheng Wang
Bioinformatics (Oxford, England)|October 1, 2013
Fuzzy optimization for detecting enzyme targets of human uric acid metabolismKai-Cheng Hsu, Feng-Sheng Wang
Plos One|June 15, 2017
Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivityKai-Cheng Hsu, Feng-Sheng Wang
Computers in Biology and Medicine|September 14, 2010
Detection of seizures in EEG using subband nonlinear parameters and genetic algorithmKai-Cheng Hsu, Sung-Nien Yu
Marine Drugs|December 2, 2017
Structural Insights into the Cytotoxic Mechanism of Vibrio parahaemolyticus PirA<sup>vp</sup> and PirB<sup>vp</sup> ToxinsShin-Jen Lin, Kai-Cheng Hsu, Hao-Ching Wang
International Journal of Data Mining and Bioinformatics|April 7, 2012
GemAffinity: a scoring function for predicting binding affinity and virtual screeningKai-Cheng Hsu, Yen-Fu Chen, Jinn-Moon Yang
Journal of Environmental Management|March 22, 2026
Environmental impact level prediction for inorganic and organic chemicals using machine learning models and interpretability analysisChao-Hsu Yang, Kai-Cheng Hsu, Pei-Te Chiueh
BMC Bioinformatics|February 24, 2011
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysisKai-Cheng Hsu, Yen-Fu Chen, Shen-Rong Lin, et al.
American Journal of Cancer Research|November 14, 2019
p38α/S1P/SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinomaPei-Ming Yang, Yi-Han Hong, Kai-Cheng Hsu, et al.
Molecules (Basel, Switzerland)|December 3, 2020
Anti-Inflammatory and Tau Phosphorylation-Inhibitory Effects of EupatinChing-Hsuan Chou, Kai-Cheng Hsu, Tony Eight Lin, et al.
Pageof 18